Top papers in Nature Reviews Drug Discovery

The papers Nature Reviews Drug Discovery published in the past week, month and year, most cited first. New lists every week.

Publisher
Nature Portfolio
Citations per paper
15.9 two-year mean, OpenAlex
Papers in 2025
241
On the stands for
Pharmacology, Toxicology and Pharmaceutics
Time

Updated 18 Nov 2026. New lists every week.

Top Nature Rev. Drug Discovery papers of the past year

Most cited first, out of 230 papers it published.

  1. 1
    Epigenetic editing: from concept to clinicNature Rev. Drug DiscoveryElizabeth A. Heller and 2 others24 Nov 2025
    42 citationsOpen full text
  2. 2
    Artificial intelligence in drug discovery — what it is, where we stand and the path forwardNature Rev. Drug DiscoveryAndreas Bender and 15 others7 Aug 2026
    39 citations
  3. 3
    Target identification and assessment in the era of AINature Rev. Drug DiscoveryFrank W. Pun and 9 others20 Apr 2026
    38 citations
  4. 4
    Roads and detours for CAR T cell therapy in autoimmune diseasesNature Rev. Drug DiscoveryJérôme Avouac and 13 others26 Jan 2026
    27 citationsOpen PDF
  5. 5
    Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indicationsNature Rev. Drug DiscoveryT. Haikarainen and 3 others5 Jan 2026
    21 citations
  6. 6
    20 citations
  7. 7
    The expanding role of formulations to enable oral delivery of poorly water-soluble drugsNature Rev. Drug DiscoveryKeisuke Ueda and 3 others2 Apr 2026
    20 citations
  8. 8
    A renaissance in targeting the PI3K/AKT/mTOR pathwayNature Rev. Drug DiscoverySarah E. Conduit and 4 others30 Mar 2026
    20 citations
  9. 9
    The evolving landscape of obesity pharmacotherapyNature Rev. Drug DiscoveryJonas Petersen and 4 others13 May 2026
    19 citations
  10. 10
    Towards mRNA therapeutics 2.0Nature Rev. Drug DiscoveryKenneth R. Chien and 2 others3 Jun 2026
    17 citations

Questions about Nature Reviews Drug Discovery

What are the most-cited Nature Rev. Drug Discovery papers of October 2026?

The most cited is “Translating base editors: a decade of progress from the bench to the clinic” (1 citation), then “Next-generation immune cell engagers for B cell depletion in autoimmune diseases” (1 citation). The list on this page has the top 10, most cited first, counted from OpenAlex.

What is the impact factor of Nature Reviews Drug Discovery?

Clarivate’s Journal Impact Factor is licensed and not shown here. OpenAlex’s two-year mean citedness, a close measure, is 15.9 for Nature Reviews Drug Discovery: on average, each paper it published in the two years before was cited about 15.9 times in a year.

How many papers does Nature Reviews Drug Discovery publish?

241 works in 2025, by OpenAlex’s count of what it published that year.

Who publishes Nature Reviews Drug Discovery?

Nature Portfolio.

Other Pharmacology, Toxicology and Pharmaceutics journals

Every journal, field by field

Bibliographic data and citation counts from OpenAlex (CC0), compiled 18 Nov 2026.